Disc Medicine, Inc. (IRON)
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Disc Medicine, Inc.
NASDAQ:IRONHealthcare · Biotechnology
-0.69%$74.51
AH Close$74.83+0.43%vs close
AH Close$74.83+0.43%vs close
Mkt Cap$3.31B
Float32.73M
O/S44.39M
Inst Own98.0%
SI22.2%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$212.18M
Total Assets$806.88M
Free Cash Flow-$181.33M
Debt & Equity
Debt 0%
Equity 100%
Total Debt$1.86M
Total Equity$739.83M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in IRON's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$806.88M
Liabilities$67.05M
Accounts Receivable$0
Accounts Payable$9.02M
Inventory$0
PP&E (Net)$2.25M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $322K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | -$322K |
| Gross Margin | - | - | - | - | - | - |
| Research and Development | $170.64M | $96.67M | $69.26M | $33.44M | $25.17M | $28.17M |
| Selling, General, and Administrative | $65.38M | $33.05M | $21.86M | $14.04M | $5.76M | $5.87M |
| Other | $0 | $0 | $0 | $0 | $0 | -$322K |
| Total Operating Expenses | $236.02M | $129.72M | $91.13M | $47.48M | $30.93M | $33.72M |
| Operating Income (EBIT) | -$236.02M | -$129.72M | -$91.13M | -$47.48M | -$30.93M | -$34.04M |
| Operating Margin | - | - | - | - | - | - |
| Interest Expense | $3.61M | $572K | $0 | $0 | $2.16M | $6.83M |
| Interest Income | $27.76M | $21.29M | $14.8M | $709K | $14K | $37K |
| Other Income (Expense) | $24.2M | $20.72M | $14.79M | $648K | -$5.04M | -$6.8M |
| Income Before Tax (EBT) | -$211.82M | -$109M | -$76.33M | -$46.83M | -$35.97M | -$40.84M |
| Income Tax Expense | $361K | $355K | $99K | $0 | $0 | $0 |
| Net Income | -$212.18M | -$109.36M | -$76.43M | -$46.83M | -$35.97M | -$40.84M |
| Net Income Margin | - | - | - | - | - | - |
| Supplementary Data | ||||||
| EPS | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| Diluted EPS | -6.01 | -3.96 | -3.42 | -45.05 | -44.88 | -27.02 |
| Weighted Average OS | 35.30M | 27.61M | 22.32M | 1.04M | 801,467 | 1.51M |
| EBITDA | -$207.94M | -$108.27M | -$76.23M | -$46.74M | -$33.78M | -$33.69M |
| EBITDA Margin | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Assets | ||||||
| Current Assets | ||||||
| Cash and Cash Equivalents | $91.14M | $192.43M | $360.38M | $194.61M | $88.04M | $4.5M |
| Short-Term Investments | $700.01M | $297.45M | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $791.15M | $489.88M | $360.38M | $194.61M | $88.04M | $4.5M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $12.75M | $3.73M | $0 | $0 | -$802K | $0 |
| Total Current Assets | $803.9M | $493.62M | $365.66M | $198.49M | $90.48M | $5.07M |
| Long-Term Assets | ||||||
| Property, Plant & Equipment Net | $2.25M | $2.32M | $2.1M | $1.6M | $1.75M | $294K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $726K | $838K | $234K | $116K | $180K | $2.96M |
| Total Long-Term Assets | $2.98M | $3.16M | $2.33M | $1.71M | $1.93M | $3.25M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $806.88M | $496.77M | $368M | $200.21M | $92.41M | $8.32M |
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts Payable | $9.02M | $7.95M | $12.63M | $16.16M | $2.56M | $2.38M |
| Short-Term Debt | $611K | $0 | $0 | $0 | $5M | $16.69M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $100K |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $27.01M | $7.21M | $5.79M | $3.62M | $1.45M | $0 |
| Total Current Liabilities | $36.64M | $23.32M | $21.44M | $22.58M | $13.42M | $24.88M |
| Long-Term Liabilities | ||||||
| Long-Term Debt | $1.25M | $28.32M | $0 | $0 | $404K | $4.95M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $29.16M | $0 | $0 | $0 | $141.45M | $353K |
| Total Long-Term Liabilities | $30.41M | $29.87M | $1.44M | $1.03M | $143.19M | $5.3M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $67.05M | $53.19M | $22.88M | $23.61M | $156.61M | $30.18M |
| Stockholders' Equity | ||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $4K | $3K | $2K | $2K | $0 | $2K |
| Retained Earnings | -$510.19M | -$298M | -$188.65M | -$112.22M | -$65.39M | -$112.82M |
| Comprehensive Income & Other | $965K | $289K | $0 | $0 | $0 | $0 |
| Other Stockholders' Equity | $1.25B | $741.59M | $533.76M | $288.81M | $1.19M | $90.96M |
| Total Equity | $739.83M | $443.59M | $345.12M | $176.6M | -$64.2M | -$21.86M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $806.88M | $496.77M | $368M | $200.21M | $92.41M | $8.32M |
| Supplementary Data | ||||||
| Total Debt | $1.86M | $30M | $2.1M | $1.33M | $7.06M | $21.64M |
| Net Debt | -$89.28M | -$162.43M | -$358.28M | -$193.28M | -$80.98M | $17.14M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
| Operating Activities | ||||||
| Net Income | -$212.18M | -$109.36M | -$76.43M | -$46.83M | -$35.97M | -$40.84M |
| Depreciation & Amortization | $281K | $156K | $100K | $89K | $32K | $322K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $34.34M | $16.82M | $5.53M | $2.09M | $507K | $983K |
| Changes in Working Capital: | ||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $1.07M | -$4.68M | -$3.74M | $526K | $1.31M | -$2.41M |
| Other Working Capital | $2.46M | $7.91M | $788K | $1.6M | -$29K | $2.75M |
| Total Working Capital Change | $3.53M | $3.23M | -$2.95M | $2.13M | $1.29M | $337K |
| Other Non-Cash Items | -$6.36M | -$4.77M | $290K | $272K | $6.61M | $6.49M |
| Net Cash from Operating | -$180.39M | -$93.93M | -$73.46M | -$42.25M | -$27.53M | -$32.71M |
| Investing Activities | ||||||
| Capital Expenditures | -$933K | -$505K | -$89K | -$151K | -$68K | -$22K |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$849.59M | -$386.63M | $0 | $0 | $0 | $0 |
| Sales of Investments | $456.22M | $94.8M | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$394.3M | -$292.33M | -$89K | -$151K | -$68K | -$22K |
| Financing Activities | ||||||
| Debt Repaid | - | -$28.99M | - | - | $4.58M | -$14M |
| Common Stock Issuance | $472.83M | $187.3M | $199.08M | $53.5M | $68K | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $578K | $2.02M | $40.3M | $95.48M | $4.58M | $163K |
| Net Cash from Financing | $473.41M | $218.31M | $239.38M | $148.98M | $89.93M | $34.25M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$101.28M | -$167.94M | $165.83M | $106.58M | $62.33M | $1.52M |
| Supplementary Data | ||||||
| Operating Cash Flow | -$180.39M | -$93.93M | -$73.46M | -$42.25M | -$27.53M | -$32.71M |
| Capital Expenditure | -$933K | -$505K | -$89K | -$151K | -$68K | -$22K |
| Free Cash Flow | -$181.33M | -$94.43M | -$73.55M | -$42.4M | -$27.6M | -$32.73M |
| Cash at Beginning | $192.67M | $360.62M | $194.79M | $88.21M | $25.89M | $3.31M |
| Cash at End | $91.39M | $192.67M | $360.62M | $194.79M | $88.21M | $4.83M |